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Abstract
This is an introduction to the supplement to BMC Medical Genomics that includes16 papers selected from the 2011
World Congress in Computer Science, Computer Engineering, Applied Computing as well as other sources with a
focus on genomics studies with a focus on human diseases.
This supplement is dedicated to the World Congress in
Computer Science, Computer Engineering, and Applied
Computing on July 18-21 in 2011 in Las Vegas, Nevada.
The congress drew a wide attention from computer scien-
tists, applied mathematicians and statisticians, bioinforma-
ticians, and researchers in many other fields. As one of the
fastest developing fields, genomics became a prominent
area that drew attentions from most attendants. Noting
that a substantial part of genomics work was dedicated to
human disease studies, we decided to launch a supplement
to BMC Medical Genomics with manuscripts selected
from this congress as well as invited submissions. More
than 30 manuscripts were submitted to this supplement.
Each manuscript was reviewed by at least two reviewers in
addition to the review by the editorial board. We hope
that the selected 15 manuscripts represent the current
success and challenges of medical genomics research and
indicate the future direction.
The genetic heterogeneity and the complicated molecu-
lar mechanism underlying tumor progression have made
it highly difficult to develop sustainable approaches for
cancer therapy. The explosion of knowledge about global
gene alterations and genomic variations has changed the
traditional approaches of cancer research and presented a
promising foundation for diagnosis and treatment of
cancer. Much effort of this supplement is devoted to can-
cer research with various types of genomics data in terms
of early diagnosis, biomarker identification, cancer classifi-
cation and therapy. Wang et al. [1] proposed a Chi-square
statistic based Top Score Genes (Chi-TSG) method for
tumor classification using global gene expression data.
They tested multiple cancer datasets and found their algo-
rithm had better performance in comparison to other
widely-used classifiers, such as Top Scoring Pair, Support
Vector Machines and Prediction Analysis of Microarrays.
A manuscript by Zhang and Chen [2] also explored cancer
classification by developing multiple distance metrics for
proteomics data. Their data showed correct identification
of breast cancer subtypes and molecular pathways. A pre-
dictive model, Support Vector Machine based on Recur-
sive Feature Elimination and Cross Validation (SVM-RFE-
CV), was proposed by Zhang, Deng and Drabier [3] for
breast cancer early detection using microarray data col-
lected from peripheral blood. Their method identified a
small group of biomarker genes for early diagnosis, which
is potentially more convenient and accurate than the tradi-
tional diagnosis using tissue biopsies and mammography.
Cancer detection and prediction was developed in non-
small cell lung carcinoma (NSCLC) by Tran [4]. His
method based on generalized Lorenz curves and Gini
ratios identified a set of 9 genes from the NSCLC gene
expression profiles and these biomarker genes can be used
for cancer prediction. Epigenetic variation can be used for
cancer early detection and classification as well. Chen
et al. [5] proposed a nonparametric method for detecting
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differentially methylated loci and suggested its application
in cancer diagnosis and classification.
Gene pathway and networking is another major focus of
this special issue. Garrett et al. [6] investigated the mole-
cular changes for human proximal tubule cells in the short
and long term exposure of cadmium. The short and long
term exposure in cells represented the acute and chronic
toxic response of human kidney. Varying exposure time
and cadmium concentration enabled them to conduct
gene pathway analysis and construct gene networks model
for toxic response by heavy metal. Pathway analysis was
carried out by Liu et al. [7] to investigate potential com-
mon molecular mechanism underlying two complex dis-
eases, Schizophrenia and type 2 diabetes mellitus. The
protein-protein network revealed high connectivity hub
proteins that were involved in a few important signal path-
ways for both diseases. Gene order is an emerging way for
gene clustering and molecular pattern discovery. By com-
bining transcriptome data with lipidomics data, Zhao et al.
[8] identified activated pathways during type 2 diabetes
development. Hu et al. [9] compared a few distance
metrics using genetic algorithm and Ant Colony Optimi-
zation for computing gene order and found that the opti-
mized method worked well for Alzheimer’s disease
microarray data.
The manuscripts of this supplement cover various data
types and broad topics. ChIP-Seq of RNA Pol II was used
to identify the bidirectional promoter by detecting bi-peak
shapes using computational approach [10]. Qureshi and
Sacan [11] proposed a weighted normalization method for
microRNA RT-PCR data. Juan et al. [12] investigated the
interaction between microRNAs and long intergenic non-
coding RNAs microRNAs. Such interactions were implied
in breast cancer development. Wang et al. [13] developed
a single gene sequencing technique for genotyping hepati-
tis B virus and detecting gene mutation for drug resis-
tance. Zheng et al. [14] proposed a support vector
machine-based machine learning method to predict DNA
methylation status, which may have broad applications in
disease studies. Teng, Yang and Wang [15] developed a
machine learning method to predict the human tissue-spe-
cific genes from microarray data and UniProt database.
Their method may be useful for understanding the mole-
cular mechanisms underlying tissue-specific diseases.
Lastly, we would like to introduce a database for disease
associated mutations. The database, HDAM, is con-
structed by Jia et al. [16] using next generation sequencing
data. HDAM currently assembled 1,114 mutations
accounting for 669 genes and 125 human diseases.
In short, this special issue brings forth many exciting
scientific discoveries and methodology advances that pre-
sent the cutting edge development of genomics research
in human diseases. We hope that it would provide
guidance for the questions and attempts in current geno-
mics research and stimulate ideas for future studies.
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